1. Home
  2. TECX vs ARAI Comparison

TECX vs ARAI Comparison

Compare TECX & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • ARAI
  • Stock Information
  • Founded
  • TECX 2019
  • ARAI N/A
  • Country
  • TECX United States
  • ARAI United States
  • Employees
  • TECX N/A
  • ARAI N/A
  • Industry
  • TECX
  • ARAI Diversified Commercial Services
  • Sector
  • TECX
  • ARAI Finance
  • Exchange
  • TECX Nasdaq
  • ARAI Nasdaq
  • Market Cap
  • TECX 334.4M
  • ARAI 299.8M
  • IPO Year
  • TECX 2018
  • ARAI N/A
  • Fundamental
  • Price
  • TECX $21.51
  • ARAI $5.84
  • Analyst Decision
  • TECX Buy
  • ARAI
  • Analyst Count
  • TECX 6
  • ARAI 0
  • Target Price
  • TECX $79.20
  • ARAI N/A
  • AVG Volume (30 Days)
  • TECX 172.8K
  • ARAI N/A
  • Earning Date
  • TECX 05-08-2025
  • ARAI N/A
  • Dividend Yield
  • TECX N/A
  • ARAI N/A
  • EPS Growth
  • TECX N/A
  • ARAI N/A
  • EPS
  • TECX N/A
  • ARAI N/A
  • Revenue
  • TECX N/A
  • ARAI N/A
  • Revenue This Year
  • TECX N/A
  • ARAI N/A
  • Revenue Next Year
  • TECX N/A
  • ARAI N/A
  • P/E Ratio
  • TECX N/A
  • ARAI N/A
  • Revenue Growth
  • TECX N/A
  • ARAI N/A
  • 52 Week Low
  • TECX $13.70
  • ARAI N/A
  • 52 Week High
  • TECX $61.07
  • ARAI N/A
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • ARAI N/A
  • Support Level
  • TECX $21.20
  • ARAI N/A
  • Resistance Level
  • TECX $22.75
  • ARAI N/A
  • Average True Range (ATR)
  • TECX 1.43
  • ARAI 0.00
  • MACD
  • TECX 0.01
  • ARAI 0.00
  • Stochastic Oscillator
  • TECX 41.32
  • ARAI 0.00

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: